Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks.

Pivetta T, Isaia F, Trudu F, Pani A, Manca M, Perra D, Amato F, Havel J.

Talanta. 2013 Oct 15;115:84-93. doi: 10.1016/j.talanta.2013.04.031. Epub 2013 Apr 18.

PMID:
24054565
3.

Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.

Pivetta T, Lallai V, Valletta E, Trudu F, Isaia F, Perra D, Pinna E, Pani A.

J Inorg Biochem. 2015 Oct;151:107-14. doi: 10.1016/j.jinorgbio.2015.05.004. Epub 2015 May 14.

PMID:
26021964
4.

Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways.

Tang J, Karhinen L, Xu T, Szwajda A, Yadav B, Wennerberg K, Aittokallio T.

PLoS Comput Biol. 2013;9(9):e1003226. doi: 10.1371/journal.pcbi.1003226. Epub 2013 Sep 12.

5.
6.
7.
8.

Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.

Pivetta T, Isaia F, Verani G, Cannas C, Serra L, Castellano C, Demartin F, Pilla F, Manca M, Pani A.

J Inorg Biochem. 2012 Sep;114:28-37. doi: 10.1016/j.jinorgbio.2012.04.017. Epub 2012 May 4.

PMID:
22687563
9.

In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2.4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines.

Deegan C, Coyle B, McCann M, Devereux M, Egan DA.

Chem Biol Interact. 2006 Dec 1;164(1-2):115-25. Epub 2006 Sep 16.

PMID:
17030029
10.

Design and sample size for evaluating combinations of drugs of linear and loglinear dose-response curves.

Fang HB, Tian GL, Li W, Tan M.

J Biopharm Stat. 2009 Jul;19(4):625-40. doi: 10.1080/10543400902964019.

PMID:
20183430
11.

Enhancement of 5-fluorouracil cytotoxicity by cisplatin in brain tumour cell lines.

Mineura K, Kowada M.

Cell Biol Int. 1996 May;20(5):355-7.

PMID:
8688852
12.

alpha-Mangostin enhances betulinic acid cytotoxicity and inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells.

Aisha AF, Abu-Salah KM, Ismail Z, Majid AM.

Molecules. 2012 Mar 8;17(3):2939-54. doi: 10.3390/molecules17032939.

14.

Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines.

Janss AJ, Cnaan A, Zhao H, Shpilsky A, Levow C, Sutton L, Phillips PC.

Anticancer Drugs. 1998 Aug;9(7):641-52.

PMID:
9773809
15.

Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.

Ibrahim T, Liverani C, Mercatali L, Sacanna E, Zanoni M, Fabbri F, Zoli W, Amadori D.

Int J Oncol. 2013 Apr;42(4):1263-70. doi: 10.3892/ijo.2013.1809. Epub 2013 Feb 6.

PMID:
23403907
16.

Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.

Serova M, Calvo F, Lokiec F, Koeppel F, Poindessous V, Larsen AK, Laar ES, Waters SJ, Cvitkovic E, Raymond E.

Cancer Chemother Pharmacol. 2006 Apr;57(4):491-9. Epub 2005 Aug 2.

PMID:
16075278
17.
18.

Probenecid is a chemosensitizer in cancer cell lines.

Campos-Arroyo D, Martínez-Lazcano JC, Melendez-Zajgla J.

Cancer Chemother Pharmacol. 2012 Feb;69(2):495-504. doi: 10.1007/s00280-011-1725-6. Epub 2011 Aug 23.

PMID:
21861129
19.

Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2.

Romanini A, Sobrero AF, Chou TC, Sherwood RF, Bertino JR.

Cancer Res. 1989 Nov 1;49(21):6019-23.

20.

Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines.

Adjei AA, Davis JN, Bruzek LM, Erlichman C, Kaufmann SH.

Clin Cancer Res. 2001 May;7(5):1438-45.

Items per page

Supplemental Content

Write to the Help Desk